| Trial name or title |
Omega 3 fatty acid treatment in patients with epilepsy |
| Methods |
Double‐blind, placebo‐controlled randomised intervention trial |
| Participants |
People with refractory idiopathic epilepsy, aged 17 to 50 years, male or female |
| Interventions |
Active supplement (contains 1.5 g DHA and 390 mg EPA) |
| Outcomes |
Complete elimination or reduction in the frequency of seizures; improvements of cognition, memory, and manifestations of behavioural and psychiatric disorders; modulation of clinical markers of cardiac arrhythmias; down‐regulation of inflammatory markers |
| Starting date |
May 2014 |
| Contact information |
Prof Kebreab Ghebremeskel (k.ghebremeskel@londonmet.ac.uk) |
| Notes |
http://isrctn.com/ISRCTN57643242 |
